Cross, but not direct, presentation of cell-associated virus antigens by spleen macrophages is influenced by their differentiation state

Immunology and Cell Biology

Volumn 88, Issue 1, 2010, Pages 3-12

  Alatery, Attiya ^a   Siddiqui, Sarah ^a   Chan, Matthew ^a   Kus, Agnieszka ^a,b   Petrof, Elaine O ^a   Basta, Sameh ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Bone marrow; Differentiation; Macrophages; Mouse; Spleen

Indexed keywords

COLONY STIMULATING FACTOR 1; VIRUS ANTIGEN; EPITOPE;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS PRESENTATION; DOWN REGULATION; HUMAN; HUMAN CELL; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MACROPHAGE; MOUSE; NONHUMAN; PHAGOSOME; SPLEEN CELL; T LYMPHOCYTE; ANIMAL; BONE MARROW; C57BL MOUSE; CELL CULTURE; CYTOLOGY; IMMUNOLOGY; PHAGOCYTOSIS; SPLEEN;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; BONE MARROW; CELL DIFFERENTIATION; CELLS, CULTURED; CROSS-PRIMING; EPITOPES, T-LYMPHOCYTE; HUMANS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MACROPHAGES; MICE; MICE, INBRED C57BL; PHAGOCYTOSIS; SPLEEN; T-LYMPHOCYTES;

EID: 74249113267     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2009.90     Document Type: Article

References (69)

1. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35.
2. Gordon S. The macrophage: past, present and future. Eur J Immunol 2007; 37 (Suppl 1): 9-17.
3. Hume DA. Macrophages as APC and the dendritic cell myth. J Immunol 2008; 181: 5829-5835.
4. Selgrade MK, Osborn JE. Role of macrophages in resistance to murine cytomegalovirus. Infect Immun 1974; 10: 1383-1390.
5. Basta S, Knoetig SM, Spagnuolo-Weaver M, Allan G, McCullough KC. Modulation of monocytic cell activity and virus susceptibility during differentiation into macrophages. J Immunol 1999; 162: 3961-3969.
6. Bruinink A, Haller O. Macrophage immunity to influenza virus: in vitro and in vivo studies. Exp Cell Biol 1979; 47: 190-201.
7. Bauer D, Schmitz A, Van Rooijen N, Steuhl KP, Heiligenhaus A. Conjunctival macrophage- mediated influence of the local and systemic immune response after corneal herpes simplex virus-1 infection. Immunology 2002; 107: 118-128.
8. Pozzi LA, Maciaszek JW, Rock KL. Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells. J Immunol 2005; 175: 2071-2081.
9. Ciavarra RP, Buhrer K, Van Rooijen N, Tedeschi B. T cell priming against vesicular stomatitis virus analyzed in situ: red pulp macrophages, but neither marginal metallophilic nor marginal zone macrophages, are required for priming CD4+ and CD8+ T cells. J Immunol 1997; 158: 1749-1755.
10. Debrick JE, Campbell PA, Staerz UD. Macrophages as accessory cells for class I MHCrestricted immune responses. J Immunol 1991; 147: 2846-2851.
11. Bohm W, Schirmbeck R, Elbe A, Melber K, Diminky D, Kraal G et al. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. J Immunol 1995; 155: 3313-3321.
12. Martinez-Pomares L, Gordon S. Antigen presentation the macrophage way. Cell 2007; 131: 641-643.
13. Ciavarra RP, Taylor L, Greene AR, Yousefieh N, Horeth D, van Rooijen N et al. Impact of macrophage and dendritic cell subset elimination on antiviral immunity, viral clearance and production of type 1 interferon. Virology 2005; 342: 177-189.
14. Nair S, Buiting AM, Rouse RJ, Van Rooijen N, Huang L, Rouse BT. Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. Int Immunol 1995; 7: 679-688.
15. Basta S, Alatery A. The cross-priming pathway: a portrait of an intricate immune system. Scand J Immunol 2007; 65: 311-319.
16. Brode S, Macary PA. Cross-presentation: dendritic cells and macrophages bite off more than they can chew!. Immunology 2004; 112: 345-351.
17. Rock KL, Shen L. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol Rev 2005; 207: 166-183.
18. Heath WR, Belz GT, Behrens GM, Smith CM, Forehan SP, Parish IA et al. Crosspresentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 2004; 199: 9-26.
19. Ramirez MC, Sigal LJ. Macrophages and dendritic cells use the cytosolic pathway to rapidly cross-present antigen from live, vaccinia-infected cells. J Immunol 2002; 169: 6733-6742.
20. Basta S, Stoessel R, Basler M, van den Broek M, Groettrup M. Cross-presentation of the long-lived lymphocytic choriomeningitis virus nucleoprotein does not require neosynthesis and is enhanced via heat shock proteins. J Immunol 2005; 175: 796-805.
21. Wijburg OL, van den Dobbelsteen GP, Vadolas J, Sanders A, Strugnell RA, van Rooijen N. The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens. Eur J Immunol 1998; 28: 479-487.
22. Kovacsovics-Bankowski M, Clark K, Benacerraf B, Rock KL. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci USA 1993; 90: 4942-4946.
23. Kovacsovics-Bankowski M, Rock KL. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines. Eur J Immunol 1994; 24: 2421-2428.
24. Harding CV, Song R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J Immunol 1994; 153: 4925-4933.
25. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S. Macrophage receptors and immune recognition. Annu Rev Immunol 2005; 23: 901-944.
26. Taylor PR, Gordon S. Monocyte heterogeneity and innate immunity. Immunity 2003; 19: 2-4.
27. Alatery A, Basta S. An efficient culture method for generating large quantities of mature mouse splenic macrophages. J Immunol Methods 2008; 338: 47-57.
28. Houde M, Bertholet S, Gagnon E, Brunet S, Goyette G, Laplante A et al. Phagosomes are competent organelles for antigen cross-presentation. Nature 2003; 425: 402-406.
29. Guermonprez P, Saveanu L, Kleijmeer M, Davoust J, Van Endert P, Amigorena S. ERphagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 2003; 425: 397-402.
30. Savina A, Jancic C, Hugues S, Guermonprez P, Vargas P, Moura IC et al. NOX2 controls phagosomal pH to regulate antigen processing during cross-presentation by dendritic cells. Cell 2006; 126: 205-218.
31. Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 2005; 307: 1630-1634.
32. Schnorrer P, Behrens GM, Wilson NS, Pooley JL, Smith CM, El-Sukkari D et al. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proc Natl Acad Sci USA 2006; 103: 10729-10734.
33. Han S, Song Y, Lee YH, Lee YR, Lee CK, Cho K et al. Macrophage-colony stimulating factor enhances MHC-restricted presentation of exogenous antigen in dendritic cells. Cytokine 2005; 32: 187-193.
34. Shen Z, Reznikoff G, Dranoff G, Rock KL. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 1997; 158: 2723-2730.
35. Hotta C, Fujimaki H, Yoshinari M, Nakazawa M, Minami M. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells. Immunology 2006; 117: 97-107.
36. Palmowski MJ, Gileadi U, Salio M, Gallimore A, Millrain M, James E et al. Role of immunoproteasomes in cross-presentation. J Immunol 2006; 177: 983-990.
37. Lin ML, Zhan Y, Villadangos JA, Lew AM. The cell biology of cross-presentation and the role of dendritic cell subsets. Immunol Cell Biol 2008; 86: 353-362.
38. Leon B, Lopez-Bravo M, Ardavin C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 2007; 26: 519-531.
39. Villadangos JA. Hold on, the monocytes are coming!. Immunity 2007; 26: 390-392.
40. Tacke F, Ginhoux F, Jakubzick C, van Rooijen N, Merad M, Randolph GJ. Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery. J Exp Med 2006; 203: 583-597.
41. Oehen S, Odermatt B, Karrer U, Hengartner H, Zinkernagel R, López-Macías C. Marginal zone macrophages and immune responses against viruses. J Immunol 2002; 169: 1453-1458.
42. Seiler P, Aichele P, Odermatt B, Hengartner H, Zinkernagel RM, Schwendener RA. Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection. Eur J Immunol 1997; 27: 2626-2633.
43. Dunbar E, Alatery A, Basta S. Cross-priming of a single viral protein from lymphocytic choriomeningitis virus alters immunodominance hierarchies of CD8(+) T cells during subsequent viral infections. Viral Immunol 2007; 20: 585-598.
44. Norbury CC, Basta S, Donohue KB, Tscharke DC, Princiotta MF, Berglund P et al. CD8+ T cell cross-priming via transfer of proteasome substrates. Science 2004; 304: 1318-1321.
45. Fadok VA, Bratton DL, Guthrie L, Henson PM. Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases. J Immunol 2001; 166: 6847-6854.
46. Yamazaki T, Nagata K, Kobayashi Y. Cytokine production by M-CSF- and GM-CSFinduced mouse bone marrow-derived macrophages upon co-culturing with late apoptotic cells. Cell Immunol 2008; 251: 124-130.
47. Kotturi MF, Scott I, Wolfe T, Peters B, Sidney J, Cheroutre H et al. Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance. J Immunol 2008; 181: 2124-2133.
48. Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 2003; 421: 852-856.
49. Hervas-Stubbs S, Olivier A, Boisgerault F, Thieblemont N, Leclerc C. TLR3 ligand stimulates fully functional memory CD8+ T cells in the absence of CD4+ T-cell help. Blood 2007; 109: 5318-5326.
50. Johnson S, Zhan Y, Sutherland RM, Mount AM, Bedoui S, Brady JL et al. Selected Tolllike receptor ligands and viruses promote helper-independent cytotoxic T cell priming by upregulating CD40 L on dendritic cells. Immunity 2009; 30: 218-227.
51. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75: 163-189.
52. Ackerman AL, Cresswell P. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat Immunol 2004; 5: 678-684.
53. Burgdorf S, Kautz A, Bohnert V, Knolle PA, Kurts C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 2007; 316: 612-616.
54. Burgdorf S, Scholz C, Kautz A, Tampé R, Kurts C. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat Immunol 2008; 9: 558-566.
55. Delamarre L, Holcombe H, Mellman I. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J Exp Med 2003; 198: 111-122.
56. Gil-Torregrosa BC, Lennon-Dumenil AM, Kessler B, Guermonprez P, Ploegh HL, Fruci D et al. Control of cross-presentation during dendritic cell maturation. Eur J Immunol 2004; 34: 398-407.
57. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 1994; 78: 761-771.
58. Goldberg AL, Cascio P, Saric T, Rock KL. The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. Mol Immunol 2002; 39: 147-164.
59. Groettrup M, Khan S, Schwarz K, Schmidtke G. Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why? Biochimie 2001; 83: 367-372.
60. Van den Eynde BJ, Morel S. Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome. Curr Opin Immunol 2001; 13: 147-153.
61. Russell DG. New ways to arrest phagosome maturation. Nat Cell Biol 2007; 9: 357-359.
62. Yates RM, Hermetter A, Russell DG. The kinetics of phagosome maturation as a function of phagosome/lysosome fusion and acquisition of hydrolytic activity. Traffic 2005; 6: 413-420.
63. Savina A, Amigorena S. Phagocytosis and antigen presentation in dendritic cells. Immunol Rev 2007; 219: 143-156.
64. Bowdish DM, Loffredo MS, Mukhopadhyay S, Mantovani A, Gordon S. Macrophage receptors implicated in the 'adaptive' form of innate immunity. Microbes Infect 2007; 9: 1680-1687.
65. Keller SA, von Allmen CE, Hinton HJ, Bauer M, Muntwiler S, Dietmeier K et al. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles. J Immunol 2009; 182: 6261-6266.
66. Johnson CR, Kitz D, Little JR. A method for the derivation and continuous propagation of cloned murine bone marrow macrophages. J Immunol Methods 1983; 65: 319-332.
67. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176: 1693-1702.
68. Shastri N, Gonzalez F. Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells. J Immunol 1993; 150: 2724-2736.
69. Petrof EO, Kojima K, Ropeleski MJ, Musch MW, Tao Y, De Simone C et al. Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 2004; 127: 1474-1487.